Free Trial

Chemed Corporation (NYSE:CHE) Shares Sold by Retirement Systems of Alabama

Chemed logo with Medical background

Retirement Systems of Alabama reduced its position in Chemed Corporation (NYSE:CHE - Free Report) by 7.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 38,706 shares of the company's stock after selling 3,312 shares during the quarter. Retirement Systems of Alabama owned about 0.26% of Chemed worth $23,817,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Allworth Financial LP lifted its holdings in shares of Chemed by 2,057.1% during the fourth quarter. Allworth Financial LP now owns 151 shares of the company's stock worth $83,000 after purchasing an additional 144 shares during the period. Principal Financial Group Inc. lifted its holdings in shares of Chemed by 114.1% during the fourth quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock worth $39,554,000 after purchasing an additional 39,791 shares during the period. CIBC Asset Management Inc lifted its holdings in shares of Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock worth $242,000 after purchasing an additional 22 shares during the period. Handelsbanken Fonder AB lifted its holdings in shares of Chemed by 2.6% during the fourth quarter. Handelsbanken Fonder AB now owns 3,972 shares of the company's stock worth $2,104,000 after purchasing an additional 100 shares during the period. Finally, Cabot Wealth Management Inc. lifted its holdings in shares of Chemed by 2.0% during the fourth quarter. Cabot Wealth Management Inc. now owns 23,421 shares of the company's stock worth $12,408,000 after purchasing an additional 460 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, EVP Spencer S. Lee sold 1,500 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total transaction of $866,985.00. Following the transaction, the executive vice president now directly owns 14,627 shares of the company's stock, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,500 shares of company stock valued at $3,213,780. Corporate insiders own 3.29% of the company's stock.

Chemed Trading Up 0.2%

Chemed stock opened at $547.06 on Friday. The stock has a market cap of $8.00 billion, a PE ratio of 26.65, a P/E/G ratio of 2.27 and a beta of 0.54. The stock has a 50-day moving average price of $567.63 and a 200 day moving average price of $564.81. Chemed Corporation has a 52 week low of $512.12 and a 52 week high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The firm had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same quarter last year, the business posted $5.20 EPS. The firm's quarterly revenue was up 9.8% compared to the same quarter last year. On average, equities analysts predict that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Investors of record on Thursday, May 29th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.37%. The ex-dividend date was Thursday, May 29th. Chemed's dividend payout ratio (DPR) is presently 9.74%.

Analyst Ratings Changes

CHE has been the subject of several research analyst reports. Royal Bank Of Canada increased their price objective on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

Read Our Latest Research Report on Chemed

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines